In addition, recent evidence has shown that pentoxifylline inhibits tumor growth and angiogenesis by inhibiting IL-6 secretion and VEGF–VEGFR2 signaling via the STAT3 signaling pathway, which is associated with the non-classical proangiogenic stem cell factor (SCF) [46]. This evidence concerns the gene KDR and neoplasm.